Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02108964 |
|---|---|
| Brief Title: | A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies |
| First Submitted : | April 7, 2014 |
| First Submitted that Met QC Criteria : | April 7, 2014 |
| First Posted : | April 9, 2014 (Estimate) |
| Results First Submitted : | October 1, 2020 |
| Results First Submitted that Met QC Criteria : | October 1, 2020 |
| Results First Posted : | October 26, 2020 |
| Certification/Extension First Submitted : | October 1, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | October 1, 2018 |
| Certification/Extension First Posted : | October 4, 2018 |
| Last Update Submitted that Met QC Criteria : | September 4, 2023 |
| Last Update Posted : | September 7, 2023 |